Faghih R et al. |
Synthesis and antibacterial activity of (9S)-9-dihydroclarithromycin. |
1990 |
J. Antibiot. |
pmid:2147921
|
Perronne C et al. |
Activities of clarithromycin, sulfisoxazole, and rifabutin against Mycobacterium avium complex multiplication within human macrophages. |
1990 |
Antimicrob. Agents Chemother. |
pmid:2171421
|
Morimoto S et al. |
Chemical modification of erythromycins. III. In vitro and in vivo antibacterial activities of new semisynthetic 6-O-methylerythromycins A, TE-031 (clarithromycin) and TE-032. |
1990 |
J. Antibiot. |
pmid:2139023
|
Kohno Y et al. |
Autobacteriographic studies of clarithromycin and erythromycin in mice. |
1990 |
Antimicrob. Agents Chemother. |
pmid:2140497
|
Marchi E |
Comparative efficacy and tolerability of clarithromycin and amoxycillin in the treatment of out-patients with acute maxillary sinusitis. |
1990 |
Curr Med Res Opin |
pmid:2140546
|
Scaglione F |
Comparison of the clinical and bacteriological efficacy of clarithromycin and erythromycin in the treatment of streptococcal pharyngitis. |
1990 |
Curr Med Res Opin |
pmid:2140547
|
Morimoto S et al. |
Chemical modification of erythromycins. VI. Structure and antibacterial activity of acid degradation products of 6-O-methylerythromycins A. |
1990 |
J. Antibiot. |
pmid:2141599
|
Hardy DJ et al. |
Enhancement of the in vitro and in vivo activities of clarithromycin against Haemophilus influenzae by 14-hydroxy-clarithromycin, its major metabolite in humans. |
1990 |
Antimicrob. Agents Chemother. |
pmid:2143642
|
Cacciapuoti AF et al. |
Microbiological and pharmacokinetic studies of acyl demycinosyltylosin and related tylosin derivatives. |
1990 |
J. Antibiot. |
pmid:2145254
|
Adachi T et al. |
Crystal and molecular structure of (14R)-14-hydroxy-6-O-methylerythromycin A. |
1989 |
J. Antibiot. |
pmid:2737946
|
Gorzynski EA et al. |
Comparative antimycobacterial activities of difloxacin, temafloxacin, enoxacin, pefloxacin, reference fluoroquinolones, and a new macrolide, clarithromycin. |
1989 |
Antimicrob. Agents Chemother. |
pmid:2524998
|
Fernandes PB et al. |
New macrolides active against Streptococcus pyogenes with inducible or constitutive type of macrolide-lincosamide-streptogramin B resistance. |
1989 |
Antimicrob. Agents Chemother. |
pmid:2523688
|
Fernandes PB et al. |
In vitro and in vivo activities of clarithromycin against Mycobacterium avium. |
1989 |
Antimicrob. Agents Chemother. |
pmid:2530933
|
Kohno Y et al. |
Comparative pharmacokinetics of clarithromycin (TE-031), a new macrolide antibiotic, and erythromycin in rats. |
1989 |
Antimicrob. Agents Chemother. |
pmid:2526615
|
Tinel M et al. |
Effects of clarithromycin on cytochrome P-450. Comparison with other macrolides. |
1989 |
J. Pharmacol. Exp. Ther. |
pmid:2527301
|
Adachi T et al. |
Hydroxylation and N-demethylation of clarithromycin (6-O-methylerythromycin A) by Mucor circinelloides. |
1989 |
J. Antibiot. |
pmid:2529234
|
Naik S and Ruck R |
In vitro activities of several new macrolide antibiotics against Mycobacterium avium complex. |
1989 |
Antimicrob. Agents Chemother. |
pmid:2817858
|
Sasaki J et al. |
Microbial transformation of 6-O-methylerythromycin derivatives. |
1988 |
J. Antibiot. |
pmid:2971032
|
Adachi T et al. |
14-Hydroxy-6-O-methylerythromycins A, active metabolites of 6-O-methylerythromycin A in human. |
1988 |
J. Antibiot. |
pmid:2971033
|
Waites KB et al. |
In vitro susceptibilities of mycoplasmas and ureaplasmas to new macrolides and aryl-fluoroquinolones. |
1988 |
Antimicrob. Agents Chemother. |
pmid:2973283
|
Barry AL et al. |
Variability of clarithromycin and erythromycin susceptibility tests with Haemophilus influenzae in four different broth media and correlation with the standard disk diffusion test. |
1988 |
J. Clin. Microbiol. |
pmid:2976773
|
Chang HR and Pechère JC |
In vitro effects of four macrolides (roxithromycin, spiramycin, azithromycin [CP-62,993], and A-56268) on Toxoplasma gondii. |
1988 |
Antimicrob. Agents Chemother. |
pmid:2837140
|
Barry AL et al. |
In vitro activities of azithromycin (CP 62,993), clarithromycin (A-56268; TE-031), erythromycin, roxithromycin, and clindamycin. |
1988 |
Antimicrob. Agents Chemother. |
pmid:2840016
|
Segreti J et al. |
In vitro activity of A-56268 (TE-031) and four other antimicrobial agents against Chlamydia trachomatis. |
1987 |
Antimicrob. Agents Chemother. |
pmid:2952061
|
Benson CA et al. |
In vitro activity of A-56268 (TE-031), a new macrolide, compared with that of erythromycin and clindamycin against selected gram-positive and gram-negative organisms. |
1987 |
Antimicrob. Agents Chemother. |
pmid:2952063
|
Barry AL et al. |
In vitro activity of a new macrolide, A-56268, compared with that of roxithromycin, erythromycin, and clindamycin. |
1987 |
Antimicrob. Agents Chemother. |
pmid:2952064
|
Chin NX et al. |
Activity of A-56268 compared with that of erythromycin and other oral agents against aerobic and anaerobic bacteria. |
1987 |
Antimicrob. Agents Chemother. |
pmid:2953303
|
Bowie WR et al. |
In vitro activity of Ro 15-8074, Ro 19-5247, A-56268, and roxithromycin (RU 28965) against Neisseria gonorrhoeae and Chlamydia trachomatis. |
1987 |
Antimicrob. Agents Chemother. |
pmid:2953304
|
Hanson CW et al. |
Regression analysis, proposed interpretative zone size standards, and quality control guidelines for a new macrolide antimicrobial agent, A-56268 (TE-031). |
1987 |
J. Clin. Microbiol. |
pmid:2954995
|
Floyd-Reising S et al. |
In vitro activity of A-56268 (TE-031), a new macrolide antibiotic, compared with that of erythromycin and other antimicrobial agents. |
1987 |
Antimicrob. Agents Chemother. |
pmid:2955742
|
Fernandes PB et al. |
Susceptibility testing of macrolide antibiotics against Haemophilus influenzae and correlation of in vitro results with in vivo efficacy in a mouse septicemia model. |
1987 |
Antimicrob. Agents Chemother. |
pmid:2957954
|
Fernandes PB et al. |
In vitro and in vivo evaluation of A-56268 (TE-031), a new macrolide. |
1986 |
Antimicrob. Agents Chemother. |
pmid:2949695
|
Morimoto S et al. |
Chemical modification of erythromycins. I. Synthesis and antibacterial activity of 6-O-methylerythromycins A. |
1984 |
J. Antibiot. |
pmid:6706855
|
Pike VW et al. |
Semi-automated preparation of a 11C-labelled antibiotic--[N-methyl-11C]erythromycin A lactobionate. |
1984 |
Int J Appl Radiat Isot |
pmid:6231252
|
Monego F et al. |
Molecular identification and typing of Mycobacterium massiliense isolated from postsurgical infections in Brazil. |
|
Braz J Infect Dis |
pmid:22230849
|
Kim MD et al. |
Ergotamine-induced upper extremity ischemia: a case report. |
|
Korean J Radiol |
pmid:15968153
|
Caliskan R et al. |
Antimicrobial resistance of Helicobacter pylori strains to five antibiotics, including levofloxacin, in Northwestern Turkey. |
|
Rev. Soc. Bras. Med. Trop. |
pmid:26108005
|
Vlachogianni P et al. |
Mycobacterium avium Auricular Infection in an Apparent Immunocompetent Patient: A Case Report. |
|
Folia Med (Plovdiv) |
pmid:27552790
|
Colomina RodrÃguez J et al. |
[Impact of Integrated Model for Rational Use of Antibiotics in a health area (project MIURA)]. |
|
Rev. Esp. Salud Publica |
pmid:20661527
|
Mégraud F |
Failed Eradication for Helicobacter pylori. What Should Be Done? |
|
Dig Dis |
pmid:27332826
|
Martins GM et al. |
MOLECULAR DETECTION OF CLARITHROMYCIN AND FLUOROQUINOLONES RESISTANCE IN HELICOBACTER PYLORI INFECTION, DIRECTLY APPLIED TO GASTRIC BIOPSIES, IN AN URBAN BRAZILIAN POPULATION. |
|
Arq Gastroenterol |
pmid:27305419
|
Wani FA et al. |
Antibiotic resistance in : A mutational analysis from a tertiary care hospital in Kashmir, India. |
|
Indian J Med Microbiol |
pmid:30084422
|
Hu JL et al. |
Optimized high-dose amoxicillin-proton-pump inhibitor dual therapies fail to achieve high cure rates in China. |
|
Saudi J Gastroenterol |
pmid:28937021
|
Melo-Cristino J et al. |
[Antimicrobial susceptibility of Streptococcus pyogenes, Haemophilus influenzae, Streptococcus pneumoniae and Moraxella catarrhalis from community acquired respiratory infections in 2000]. |
|
Acta Med Port |
pmid:11878155
|
Christodoulou C et al. |
Quetiapine and clarithromycin-induced neuroleptic malignant syndrome. |
|
Clin Neuropharmacol |
pmid:25580921
|
Feng L et al. |
Sequential Therapy or Standard Triple Therapy for Helicobacter pylori Infection: An Updated Systematic Review. |
|
Am J Ther |
pmid:25569598
|
Roig J et al. |
13--Antibiotic therapy of community-acquired pneumonia (CAP) caused by atypical agents. |
|
Med Mal Infect |
pmid:17095177
|
Asgari B et al. |
HONEY-DERIVED LACTOBACILLUS RHAMNOSUS ALLEVIATES HELICOBACTER PYLORI-INDUCED GASTRO-INTESTINAL INFECTION AND GASTRIC INFLAMMATION IN C57BL/6 MICE: AN IMMUNO-HISTOLOGIC STUDY. |
|
Arq Gastroenterol |
pmid:30540092
|
Moreira A et al. |
Is Helicobacter pylori infection associated with chronic idiopathic urticaria? |
|
Allergol Immunopathol (Madr) |
pmid:12890412
|
Lin TY et al. |
An open-label, randomized comparison of levofloxacin and amoxicillin/clavulanate plus clarithromycin for the treatment of hospitalized patients with community-acquired pneumonia. |
|
Chang Gung Med J |
pmid:17939262
|